Elahere 100 mg/20 mL (5 mg/mL) injection Images
Generic Name: mirvetuximab soravtansine
This medication has been identified as Elahere 100 mg/20 mL (5 mg/mL) injection. It is supplied by ImmunoGen, Inc.
Elahere is used in the treatment of Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer and belongs to the drug class miscellaneous antineoplastics. Elahere 100 mg/20 mL (5 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Elahere
- Generic Name
- mirvetuximab soravtansine
- Strength
- 100 mg/20 mL (5 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- ImmunoGen, Inc.
- National Drug Code (NDC)
- 72903-0853
More about Elahere (mirvetuximab soravtansine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.